BridgeBio Pharma, Inc.

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Total revenue	0.50	0.22	0.01	0.08	0.07	0.01	0.04	0.00	0.00
Cost of revenue	0.03	0.00	0.00	0.00	0.00	0.00	0.00		0.00
Gross profit	0.47	0.22	0.01	0.07	0.07	0.01	0.04		0.00
Total operating expenses +	1.04	0.81	0.61	0.59	0.64	0.48	0.30	0.18	0.04
Selling, general and administrative	0.53	0.25	0.15	0.14	0.19	0.15	0.09	0.04	0.01
Research and development	0.48	0.51	0.46	0.40	0.45	0.34	0.21	0.14	0.03
Other operating expenses	0.03	0.05	0.01	0.04	0.00	0.00	0.00	0.00	0.00
Operating income	-0.57	-0.59	-0.61	-0.51	-0.58	-0.47	-0.27	-0.18	-0.04
Non-operating income (net)	-0.17	0.05	-0.05	0.03	-0.01	-0.03	-0.02	0.01	0.00
Income before tax	-0.73	-0.54	-0.65	-0.48	-0.59	-0.51	-0.29	-0.17	-0.04
Income tax expense	0.00	0.00	0.07	0.01	0.05	-0.02	-0.03	0.02	-0.01
Net income	-0.73	-0.54	-0.64	-0.48	-0.56	-0.45	-0.26	-0.13	-0.03

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18	Mar-18
Total revenue	0.19	0.15	0.12	0.11	0.12	0.01	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.01	0.00	0.05	0.00	0.00	0.01	0.00	0.01	0.01	0.03	0.00	0.00
Cost of revenue	0.01	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00		0.00	0.00			0.00	0.00
Gross profit	0.18	0.14	0.11	0.11	0.11	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.01	0.00	0.05	0.00	0.00	0.01		0.01	0.01	0.02
Total operating expenses +	0.29	0.32	0.26	0.24	0.22	0.23	0.19	0.18	0.21	0.18	0.16	0.15	0.13	0.13	0.13	0.15	0.17	0.18	0.15	0.15	0.17	0.13	0.13	0.12	0.10	0.09	0.08	0.07	0.06	0.07	0.04	0.03	0.04
Selling, general and administrative	0.16	0.16	0.14	0.13	0.11	0.09	0.07	0.06	0.07	0.05	0.04	0.04	0.03	0.03	0.03	0.04	0.04	0.05	0.05	0.05	0.05	0.04	0.04	0.04	0.03	0.03	0.02	0.02	0.02	0.01	0.01	0.01	0.01
Research and development	0.13	0.14	0.11	0.11	0.11	0.13	0.12	0.11	0.14	0.13	0.13	0.11	0.09	0.09	0.09	0.11	0.11	0.12	0.10	0.10	0.12	0.09	0.09	0.09	0.07	0.06	0.06	0.05	0.04	0.05	0.03	0.02	0.03
Other operating expenses	0.00	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating income	-0.11	-0.19	-0.15	-0.13	-0.10	-0.23	-0.19	-0.18	0.00	-0.18	-0.16	-0.15	-0.13	-0.13	-0.13	-0.08	-0.17	-0.17	-0.15	-0.09	-0.17	-0.13	-0.12	-0.12	-0.10	-0.08	-0.05	-0.07	-0.06	-0.07	-0.04	-0.03	-0.04
Non-operating income (net)	-0.06	-0.01	-0.04	-0.05	-0.07	-0.04	0.03	0.10	-0.04	0.01	-0.02	-0.01	-0.02	-0.01	-0.01	0.08	-0.03	0.01	-0.01	-0.01	0.00	-0.01	-0.01	-0.01	0.00	-0.01	-0.01	-0.01	-0.01	0.02	0.00	0.00	0.00
Income before tax	-0.17	-0.20	-0.19	-0.18	-0.17	-0.27	-0.16	-0.08	-0.04	-0.17	-0.18	-0.16	-0.14	-0.14	-0.14	0.00	-0.20	-0.15	-0.16	-0.10	-0.17	-0.14	-0.13	-0.14	-0.10	-0.08	-0.06	-0.07	-0.07	-0.05	-0.04	-0.04	-0.04
Income tax expense			0.00	0.00	0.00	0.00		0.00	0.00	0.02	0.00	0.02	0.03	0.02	0.01	-0.06	0.05	0.02	0.01	0.00	0.01	0.04	0.00	-0.01	-0.01	0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Net income	-0.16	-0.20	-0.18	-0.18	-0.17	-0.27	-0.16	-0.07	-0.04	-0.17	-0.18	-0.16	-0.14	-0.14	-0.14	-0.01	-0.20	-0.15	-0.16	-0.10	-0.16	-0.12	-0.12	-0.12	-0.09	-0.07	-0.06	-0.07	-0.06	-0.04	-0.03	-0.03	-0.03

about 15 hours ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Total cash and short-term investments +	0.59	0.68	0.43	0.47	0.84	0.61	0.55	0.44	0.09
Cash and cash equivalents	0.57	0.68	0.38	0.38	0.39	0.36	0.36	0.44	0.09
Short-term investments	0.02	0.00	0.06	0.10	0.44	0.25	0.18
Accounts receivable, net	0.14	0.00	0.00	0.02	0.02		0.00
Inventories	0.03	0.00	0.02	0.04	-0.07
Other current assets	0.04	0.03	0.04	0.06	0.03	0.04	0.02	0.01	0.01
Total current assets	0.75	0.72	0.48	0.55	0.89	0.64	0.57	0.45	0.10
Total non-current assets +	0.04	0.20	0.07	0.07	0.12	0.06	0.06	0.02	0.00
Property, plant and equipment, net				0.01	0.05	0.02	0.01	0.00	0.00
Goodwill
Intangible assets	0.03	0.02	0.03	0.03	0.04
Long-term investments	0.08	0.14	0.00	0.04	0.05	0.00	0.03	0.02	0.00
Other non-current assets
Total assets	0.94	0.92	0.55	0.62	1.01	0.70	0.63	0.46	0.10

Total current liabilities +	0.29	0.15	0.14	0.12	0.14	0.10	0.06	0.03	0.01
Accounts payable	0.04	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00
Short-term debt	0.02	0.00	0.00	0.00	0.00	0.01	0.01
Current portion of long-term debt						0.00
Deferred revenue
Other current liabilities	0.21	0.14	0.12	0.10	0.12	0.08	0.05	0.02	0.01
Total non-current liabilities +	2.72	2.22	1.75	1.75	1.74	0.50	0.10	0.53	0.14
Long-term debt	1.85	1.72	1.73	1.71	1.70	0.48	0.09	0.05
Capital lease obligations	0.01	0.01	0.01	0.02	0.02	0.02	0.01
Other non-current liabilities	0.00	0.00	0.01	0.03	0.04	0.02	0.00	0.00	0.00
Total liabilities	3.01	2.38	1.89	1.87	1.88	0.60	0.16	0.57	0.15

Total stockholders' equity +	-2.08	-1.47	-1.35	-1.25	-0.87	0.06	0.41	-0.16	-0.06
Common stock and paid-in capital	1.74	1.63	1.21	0.66	0.57	0.95	0.85	0.01	0.00
Retained earnings	-3.82	-3.10	-2.56	-1.92	-1.44	-0.89	-0.44	-0.17	-0.06
Common shares outstanding	197	186	163	147	144	118	105	92	92

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18	Mar-18
Total cash and short-term investments +	0.94	0.59	0.65	0.76	0.54	0.68	0.27	0.59	0.52	0.43	0.54	0.38	0.52	0.47	0.59	0.72	0.67	0.84	0.60	0.84	0.92	0.61	0.71	0.84	0.91	0.55	0.54	0.29	0.37	0.44	0.00	0.00	0.09
Cash and cash equivalents	0.88	0.57	0.64	0.75	0.54	0.68	0.27	0.55	0.48	0.38	0.51	0.30	0.43	0.38	0.48	0.47	0.37	0.39	0.18	0.38	0.47	0.36	0.37	0.54	0.76	0.36	0.41	0.29	0.37	0.44			-0.09
Short-term investments	0.06	0.02	0.00	0.01		0.00	0.00	0.04	0.04	0.06	0.04	0.08	0.08	0.10	0.11	0.25	0.30	0.44	0.42	0.46	0.45	0.25	0.34	0.30	0.15	0.18	0.12						0.18
Accounts receivable, net	0.21	0.14	0.12	0.08	0.12	0.00	0.00	0.00	0.24	0.00	0.01	0.01	0.01	0.02	0.02	0.02	0.01	0.02	0.01	0.05	0.00		0.01			0.00
Inventories	0.03	0.03	0.02	0.02	0.00	0.00		-0.03		0.02	0.02	0.02	0.03	0.04		0.00		0.00		0.00						0.00
Other current assets	0.06	0.04	0.05	0.06	0.04	0.03	0.18	0.03	0.03	0.04	0.04	0.04	0.03	0.06	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.04	0.03	0.02	0.02	0.02	0.02	0.01	0.01	0.01
Total current assets	1.18	0.75	0.84	0.91	0.70	0.72	0.44	0.62	0.78	0.48	0.59	0.43	0.55	0.55	0.64	0.77	0.72	0.89	0.64	0.91	0.95	0.64	0.75	0.86	0.92	0.57	0.56	0.31	0.38	0.45			0.09
Total non-current assets +	0.05	0.04	0.16	0.17	0.19	0.20	0.22	0.18	0.07	0.07	0.07	0.07	0.07	0.07	0.09	0.09	0.10	0.12	0.14	0.17	0.15	0.06	0.04	0.04	0.06	0.06	0.08	0.02	0.02	0.02			-0.09
Property, plant and equipment, net												0.02	0.01	0.01	0.02	0.03	0.02	0.05	0.03	0.04	0.02	0.02	0.03	0.03	0.02	0.01	0.00	0.00	0.00
Goodwill
Intangible assets	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.04	0.05
Long-term investments	0.06	0.08	0.09	0.11	0.13	0.14	0.16	0.12		0.00	0.04	0.05	0.05	0.04				0.05	0.02	0.08	0.08	0.00	0.00	0.00	0.02	0.03	0.08	0.01	0.01
Other non-current assets
Total assets	1.37	0.94	1.00	1.08	0.88	0.92	0.66	0.79	0.85	0.55	0.66	0.50	0.63	0.62	0.73	0.86	0.81	1.01	0.78	1.08	1.09	0.70	0.79	0.91	0.99	0.63	0.64	0.33	0.40	0.46

Total current liabilities +	0.82	0.29	0.22	0.18	0.15	0.15	0.14	0.13	0.14	0.14	0.11	0.11	0.10	0.12	0.12	0.14	0.10	0.14	0.10	0.13	0.09	0.10	0.08	0.09	0.06	0.06	0.04	0.04	0.04	0.03
Accounts payable	0.03	0.04	0.02	0.03	0.03	0.01	0.01	0.02	0.00	0.01	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01
Short-term debt	0.57	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.01	0.00	0.01	0.01	0.00	0.00	0.00	0.01
Current portion of long-term debt	0.55																				0.00	0.00
Deferred revenue
Other current liabilities	0.20	0.21	0.18	0.12	0.12	0.14	0.11	0.10	0.11	0.12	0.10	0.10	0.08	0.10	0.10	0.12	0.09	0.12	0.08	0.10	0.07	0.08	0.06	0.08	0.05	0.05	0.03	0.02	0.02	0.02
Total non-current liabilities +	2.82	2.72	2.70	2.68	2.37	2.22	1.74	1.74	1.74	1.75	1.74	1.74	1.74	1.75	1.74	1.74	1.75	1.74	1.42	1.41	1.39	0.50	0.49	0.49	0.47	0.10	0.08	0.55	0.06	0.53
Long-term debt	1.93	1.85	1.85	1.85	1.85	1.72	1.72	1.72	1.72	1.73	1.72	1.72	1.71	1.71	1.70	1.69	1.71	1.70	1.38	1.37	1.36	0.48	0.47	0.47	0.46	0.09	0.08	0.07	0.05
Capital lease obligations	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01
Other non-current liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.03	0.03	0.04	0.04	0.04	0.04	0.05	0.01	0.03	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Total liabilities	3.64	3.01	2.92	2.86	2.52	2.38	1.88	1.88	1.89	1.89	1.85	1.85	1.84	1.87	1.86	1.88	1.85	1.88	1.52	1.54	1.48	0.60	0.57	0.58	0.54	0.16	0.12	0.59	0.09	0.57

Total stockholders' equity +	-2.27	-2.08	-1.93	-1.79	-1.65	-1.47	-1.23	-1.09	-1.05	-1.35	-1.21	-1.36	-1.23	-1.25	-1.14	-1.03	-1.04	-0.87	-0.74	-0.46	-0.40	0.06	0.16	0.27	0.38	0.41	0.46	-0.32	0.25	-0.16			0.09
Common stock and paid-in capital	1.72	1.74	1.70	1.66	1.62	1.63	1.60	1.58	1.55	1.21	1.18	0.85	0.83	0.66	0.64	0.62	0.59	0.57	0.55	0.67	0.64	0.95	0.93	0.92	0.91	0.85	0.83	0.01	0.49	0.01	0.00	0.00	0.09
Retained earnings	-3.99	-3.82	-3.63	-3.45	-3.26	-3.10	-2.83	-2.67	-2.60	-2.56	-2.39	-2.22	-2.06	-1.92	-1.78	-1.64	-1.63	-1.44	-1.29	-1.13	-1.04	-0.89	-0.77	-0.65	-0.53	-0.44	-0.37	-0.33	-0.23	-0.17
Common shares outstanding	195	197	191	191	190	189	189	188	179	174	163	161	153	149	148	147	146	145	147	147	139	119	118	117	118	118	117	93	120	92	92	92	92

about 15 hours ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Operating cash flow +	-0.45	-0.52	-0.53	-0.42	-0.50	-0.40	-0.25	-0.14	-0.04
Net income
Depreciation, depletion and amortization	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Stock-based compensation	0.13	0.10	0.12	0.09	0.10	0.06	0.02	0.01	0.00
Change in inventory	-0.03	0.00	-0.02	-0.02	0.02	0.00	0.00
Other working capital changes	-0.56	-0.62	-0.63	-0.50	-0.62	-0.46	-0.28	-0.14	-0.04
Cash flow from investing +	-0.02	0.06	0.05	0.45	-0.20	-0.05	-0.22	-0.02	0.00
Capital expenditures	0.00	0.00	0.00	-0.01	-0.05	-0.01	-0.01	-0.02	0.00
Others incl. marketable securities changes	-0.02	0.06	0.06	0.46	-0.15	-0.05	-0.21	0.00	0.00
Cash flow from financing +	0.36	0.75	0.45	-0.01	0.74	0.45	0.40	0.50	0.11
Dividend payout					0.00	-0.54	0.00	0.00	0.00
Common stock repurchases	-0.05	-0.01	-0.01	0.00	-0.20	-0.08	0.37	0.43	0.11
Net Debt Issuance	0.41	0.76	0.46	-0.01	0.95	1.06	0.03	0.07	0.01

Change in cash	-0.11	0.29	-0.02	0.02	0.04	-0.01	-0.07	0.34	0.07

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Sep-20	Jun-20	Mar-20	Dec-19	Sep-19	Jun-19	Mar-19	Dec-18	Sep-18	Jun-18	Mar-18
Operating cash flow +	-0.20	-0.06	-0.11	-0.08	-0.20	-0.20	-0.18	0.07	-0.22	-0.12	-0.15	-0.11	-0.14	-0.09	-0.14	-0.03	-0.16	-0.13	-0.12	-0.09	-0.15	-0.10	-0.13	-0.09	-0.08	-0.08	-0.05	-0.07	-0.06	-0.05	-0.04	-0.03	-0.02
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.03	0.03	0.04	0.04	0.03	0.03	0.03	0.02	0.02	0.04	0.02	0.03	0.02	0.02	0.02	0.03	0.02	0.02	0.02	0.03	0.03	0.01	0.02	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Change in inventory	-0.01	0.00	-0.01	-0.01	0.00			0.00		0.00	0.00	0.00	-0.01	-0.02	0.00	0.01						0.00	-0.03
Other working capital changes	-0.23	-0.09	-0.14	-0.11	-0.22	-0.23	-0.21	0.05	-0.24	-0.16	-0.17	-0.14	-0.16	-0.10	-0.16	-0.07	-0.19	-0.16	-0.14	-0.12	-0.18	-0.12	-0.12	-0.11	-0.09	-0.09	-0.06	-0.07	-0.06	-0.05	-0.04	-0.04	-0.02
Cash flow from investing +	-0.04	-0.01	0.00	-0.01	0.00	0.00	0.04	0.00	0.02	0.00	0.04	0.00	0.01	0.02	0.15	0.15	0.14	0.02	0.06	-0.08	-0.28	0.08	-0.05	-0.13	0.04	0.02	-0.20	0.00	0.00	0.00	0.00	0.00	-0.02
Capital expenditures	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02
Others incl. marketable securities changes	-0.04	-0.01	0.00	-0.01	0.00	0.00	0.04	0.01	0.02	0.00	0.04	0.00	0.01	0.02	0.15	0.15	0.14	0.02	0.10	-0.08	-0.28	0.09	-0.04	-0.13	0.04	0.02	-0.20	0.00	0.00	0.00	0.00	0.00	0.00
Cash flow from financing +	0.55	0.00	0.00	0.30	0.06	0.47	0.00	-0.01	0.28	0.00	0.31	0.00	0.15	0.01	0.00	-0.02	0.00	0.33	-0.14	0.08	0.55	0.00	0.00	0.00	0.44	0.00	0.37	-0.01	0.00	0.27	0.00	0.21	0.02
Dividend payout																		-0.11				0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common stock repurchases	-0.08	-0.01	0.00	0.00	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.14	-0.01	-0.05	0.00	0.00	0.00	-0.08	0.37	0.39	0.00	0.00	0.43
Net Debt Issuance	0.63	0.00	0.00	0.30	0.11	0.48	0.00	0.00	0.28	0.00	0.31	0.00	0.15	0.01	0.00	-0.02	0.00	0.44	0.01	0.09	0.60	0.01	0.00	0.00	0.51	-0.36	-0.02	-0.01	0.00	-0.16	0.00	0.21	0.02

Change in cash	0.31	-0.07	-0.11	0.21	-0.14	0.28	-0.14	0.07	0.08	-0.13	0.20	-0.11	0.02	-0.07	0.01	0.10	-0.02	0.21	-0.20	-0.09	0.12	-0.01	-0.17	-0.22	0.39	-0.05	0.12	-0.08	-0.06	0.22	-0.04	0.18	-0.02

about 15 hours ago

Ask a follow up

BridgeBio Pharma, Inc.

Income Statement - BridgeBio Pharma, Inc. (BBIO)

Income Statement - BridgeBio Pharma, Inc. (BBIO)

Balance Sheet - BridgeBio Pharma, Inc. (BBIO)

Balance Sheet - BridgeBio Pharma, Inc. (BBIO)

Cash Flow - BridgeBio Pharma, Inc. (BBIO)

Cash Flow - BridgeBio Pharma, Inc. (BBIO)